Monogram Orthopedics Stock: What Happened to MGRM?

The central fact for anyone researching Monogram Orthopedics stock is that the former public-company story has ended. Zimmer Biomet announced the completion of its acquisition of Monogram Technologies on October 7, 2025 and reported that the shares ceased trading.

Is MGRM still trading?

No. According to Zimmer Biomet’s acquisition-completion announcement, Monogram’s shares ceased trading after the transaction was completed. Historical quote pages and prior discussions of MGRM therefore describe a security that is no longer active.

Why do you see two company names?

The business appeared under both Monogram Orthopedics and Monogram Technologies. A company filing with the SEC states that its name changed from Monogram Orthopedics Inc. to Monogram Technologies Inc. on May 15, 2024.

What happened to existing shares?

Zimmer Biomet reported that each outstanding Monogram common share was converted into the right to receive $4.04 in cash and up to $12.37 in additional cash. The announcement is the relevant starting point for understanding the transaction terms; individual holders may need to consult their brokerage records and the transaction materials for how those terms applied to their holdings.

How to assess older MGRM information

Earlier descriptions of Monogram as a prospective standalone investment no longer reflect its status after the completed acquisition and the end of share trading. When reviewing an older price, forecast, or company profile, first check whether it predates the completed transaction announced on October 7, 2025.

Bottom line

MGRM is not an active standalone stock following Zimmer Biomet’s completed acquisition of Monogram Technologies. The most useful primary records supplied here are Monogram’s SEC filing covering its name change and Zimmer Biomet’s acquisition-completion announcement.